MedPath

RIVA-LOVASTATIN

RIVA-LOVASTATIN

Discontinued
DIN Number

02272288

Drug Class

Human

Market Date

Dec 1, 2005

Company
HC

laboratoire riva inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02272288
AIG Number0120669002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10AA02 LOVASTATIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:06.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

LOVASTATINActive
Strength: 20 MG
Monograph: LOVASTATIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.